Personnel Information

写真a

Yokota Takanori


Job title

Professor

Mail Address

The inquiry by e-mail is 《here

Graduating School 【 display / non-display

  • Tokyo Medical and Dental University, Faculty of Medicine, 1984, Graduated

Degree 【 display / non-display

  • Medical Doctor, Tokyo Medical and Dental University

Campus Career 【 display / non-display

  • 2014.08
    -
    2018.03
    Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Medical and Dental Sciences, Cognitive and Behavioral Medicine, Neurology and Neurological Science, Professor
  • 2018.04
    -
    2020.05
    Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Medical and Dental Sciences, Cognitive and Behavioral Medicine, Neurology and Neurological Science, Professor
  • 2020.06
    -
    Now
    Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Medical and Dental Sciences, Cognitive and Behavioral Medicine, Neurology and Neurological Science, Professor

Research Areas 【 display / non-display

  • Neurology

 

Published Papers & Misc 【 display / non-display

  • Yokote H, Toru S, Nishida Y, Hattori T, Sanjo N, Yokota T. Serum amyloid A level correlates with T2 lesion volume and cortical volume in patients with multiple sclerosis. Journal of neuroimmunology. 2021.02; 351 577466. ( PubMed, DOI )

  • Asami Y, Nagata T, Yoshioka K, Kunieda T, Yoshida-Tanaka K, Bennett CF, Seth PP, Yokota T. Efficient Gene Suppression by DNA/DNA Double-Stranded Oligonucleotide In Vivo. Molecular therapy : the journal of the American Society of Gene Therapy. 2021.02; 29 (2): 838-847. ( PubMed, DOI )

  • Shinya A, Takahashi M, Sato N, Nishida Y, Inaba A, Inaji M, Yokota T, Orimo S. A Case of Oculo-dento-digital Dysplasia Presenting as Spastic Paraparesis Which Was Successfully Treated by Intrathecal Baclofen Therapy. Internal medicine (Tokyo, Japan). 2021.02; ( PubMed, DOI )

  • Naito M, Chaya H, Toh K, Kim BS, Hayashi K, Fukushima S, Nagata T, Yokota T, Kataoka K, Miyata K. Structural tuning of oligonucleotides for enhanced blood circulation properties of unit polyion complexes prepared from two-branched poly(ethylene glycol)-block-poly(l-lysine). Journal of controlled release : official journal of the Controlled Release Society. 2021.01; 330 812-820. ( PubMed, DOI )

  • Watanabe M, Nakamura Y, Sato S, Niino M, Fukaura H, Tanaka M, Ochi H, Kanda T, Takeshita Y, Yokota T, Nishida Y, Matsui M, Nagayama S, Kusunoki S, Miyamoto K, Mizuno M, Kawachi I, Saji E, Ohashi T, Shimohama S, Hisahara S, Nishiyama K, Iizuka T, Nakatsuji Y, Okuno T, Ochi K, Suzumura A, Yamamoto K, Kawano Y, Tsuji S, Hirata M, Sakate R, Kimura T, Shimizu Y, Nagaishi A, Okada K, Hayashi F, Sakoda A, Masaki K, Shinoda K, Isobe N, Matsushita T, Kira JI. HLA genotype-clinical phenotype correlations in multiple sclerosis and neuromyelitis optica spectrum disorders based on Japan MS/NMOSD Biobank data. Scientific reports. 2021.01; 11 (1): 607. ( PubMed, DOI )

display all >>

Books etc 【 display / non-display

  • Sekiguchi T, Abe K, Ohkubo T, Kanouchi T, Yokota T. Annual Review Neurology 2014. Chugai-igaku-sha Co.,Ltd, 2014.01 Pathomechanisms of the onset and progression of amyotrophic lateral sclerosis (ALS) (ISBN : 978-4-498-22814-6)

Conference Activities & Talks 【 display / non-display

  • 横田隆徳. 脳内で効率的に作用する核酸医薬の開発. 第15回COINS全体会議 2021.01.22

  • Ishikawa K,Higashi M,Okita M,Aoki H,Asaka M,Ishiguro T,Sato N,Nagai Y,Yanagihara D,Yokota T. Pathogenesis of spinocerebellar ataxia type31(SCA31). 61st Annual Meeting of the Japanese Society of Neurology 2020.09.02 Okayama

  • Higashi M,Okita M,Sato N,Asaka M,Ishii T,Aoki H,Ishiguro T,Yanagihara D,Yokota T.Ishikawa K. SCA31 transgenic mice show pathologic features similar to human patients. 61st Annual Meeting of the Japanese Society of Neurology 2020.08.31 Okayama

  • Ohyagi M,Nagata T,Ihara K,Nishi R,Mabuchi Y,Akazawa C,Yokota T. New therapeutics strategy for multiple sclerosis by DNA/RNA heteroduplex oligonucleotide technology. 61st Annual Meeting of the Japanese Society of Neurology 2020.08.31 Okayama

  • Irioka T,Motomura M,Igarahi S,Takahahi Y,Iwase R,Otani T,Kitanosono H,Shiraihi H,Iizuka T,Yokota T. Calcium channels antibody-associated paraneoplastic disorders other than Lambert-Eaton syndrome. 61st Annual Meeting of the Japanese Society of Neurology 2020.08.31 Okayama

display all >>

Patents 【 display / non-display

  • CHIMERIC DOUBLE-STRANDED NUCLEIC ACID

    Patent Number: 10329567

  • CHIMERIC DOUBLE-STRANDED NUCLEIC ACID

    Patent Number: 10337006

  • CHIMERIC SINGLE-STRANDED ANTISENSE POLYNUCLEOTIDES AND DOUBLE-STRANDED ANTISENSE AGENT

    Patent Number: 10844374

  • CHIMERIC SINGLE-STRANDED ANTISENSE POLYNUCLEOTIDES AND DOUBLE-STRANDED ANTISENSE AGENT

    Patent Number: 2961841

  • CARRIER FOR USE IN DELIVERING DRUG, CONJUGATE, COMPOSITION COMPRISING SAME, AND METHOD FOR ADMINISTRATING SAME

    Patent Number: 9,937,263

display all >>

Others 【 display / non-display

  • 2018.06

    Journal of Controlled Release